The global unfractionated heparin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Unfractionated heparin is a fast-acting blood thinner with antithrombin, a natural protein in the body to block clot formation. The rise in the prevalence of cardiovascular diseases is one of the major factors driving the growth of […]
